Vanda Pharmaceuticals, Inc. (VNDA)
6.07
-0.07
(-1.14%)
USD |
NASDAQ |
Dec 09, 16:00
6.07
0.00 (0.00%)
After-Hours: 17:16
Vanda Pharmaceuticals Profit Margin (Quarterly): -40.15% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| ADMA Biologics, Inc. | 27.14% |
| Aldeyra Therapeutics, Inc. | -- |
| Exelixis, Inc. | 32.38% |
| Anavex Life Sciences Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.55% |
| Return on Assets | -13.33% |
| Return on Invested Capital | -16.20% |
| Gross Profit Margin (Quarterly) | 91.64% |
| Operating Margin (Quarterly) | -55.61% |
| Return on Net Operating Assets | -48.74% |